Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Maturitas(4)
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(2)
Ginecología, obstetricia, pediatría, geriatría(2)
Medicina y salud(1)
Origen
scopus(4)
Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al.
OtherAbstract:Palabras claves:Autores:Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.Fuentes:scopusDrug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
ReviewAbstract: Background Bisphosphonates and denosumab are used extensively in the treatment of postmenopausal ostPalabras claves:Alendronate, Bisphosphonates, Denosumab, Drug holiday, Risedronate, Zoledronic acidAutores:Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.Fuentes:scopusOsteoporosis management in patients with breast cancer: EMAS position statement
ReviewAbstract: Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrogPalabras claves:adjuvant therapy, Aromatase inhibitors, Bisphosphonates, Breast Cancer, Denosumab, fractures, OSTEOPOROSIS, screeningAutores:Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A., van der Schouw Y.T.Fuentes:scopusInterventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement
ReviewAbstract: Background Ovarian cancer is a leading cause of female gynecological cancer-related death, and therePalabras claves:bilateral oophorectomy, Bilateral salpingectomy, BRCA gene mutation, Combined oral contraceptives, Fallopian tubes cancer, hysterectomy, Non-steroid anti-inflammatory drugs, obesity, Ovarian borderline tumors, Ovarian Cancer, smokingAutores:Ceausu I., Depypere H., Faustino R. Pérez-López, Kehoe S., Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P.Fuentes:scopus